India's Biocon up as unit's eye drug to be launched in Canada by mid-2025
** Shares of Biocon up 3.3% at 286.2 rupees
** Co says unit Biocon Biologics' visual impairment
treatment drug Yesafili to launch in Canada by July 1, 2025
** Stock set for best day in about two weeks if trend holds
** Including BION, nine out of 20 stocks on Nifty Pharma
.NIPHARM rated "hold" on avg; rest "buy" or higher and Divi's
Labs DIVI.NS only "sell"-rated stock - LSEG data
** BION and NIPHARM each rose for four straight months in
Feb
(Reporting by Varun Vyas in Bengaluru)
((varunvyas.hebbalalu@thomsonreuters.com))
Recent news on Divi's Laboratories
See all newsDivi's Laboratories and Laurus Labs lead India's record CRDMO growth, Jefferies says
India Stocks: Indian shares inch higher to close at 8-month high as crude oil drops
India's Divi's Laboratories jumps to record high after profit jumps by nearly two thirds
Indian shares muted as markets pause after last week's rally
India Stocks: Indian shares consolidate in Diwali session after seven-day rally